Name: ION BEAM APPLICATIONS (IBAB) Stock
Brand: ION BEAM APPLICATIONS
Rating: 6.5 (3 reviews)

Question 1

Can you describe the business of ION BEAM APPLICATIONS?

Accepted Answer

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,095 full-time employees.  IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

Question 2

What is the stock price of ION BEAM APPLICATIONS today?

Accepted Answer

The current stock price of IBAB.BR is 13.53 EUR. The price decreased by -1.53% in the last trading session.

Question 3

Does ION BEAM APPLICATIONS pay dividends?

Accepted Answer

ION BEAM APPLICATIONS (IBAB.BR) has a dividend yield of 1.26%. The yearly dividend amount is currently 0.17.

Question 4

How is the ChartMill rating for ION BEAM APPLICATIONS?

Accepted Answer

IBAB.BR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.

Question 5

On which exchange is IBAB.BR stock listed?

Accepted Answer

IBAB.BR stock is listed on the Euronext Brussels exchange.

Question 6

What do analysts say about ION BEAM APPLICATIONS (IBAB.BR) stock?

Accepted Answer

10 analysts have analysed IBAB.BR and the average price target is 14.62 EUR. This implies a price increase of 8.06% is expected in the next year compared to the current price of 13.53.

ION BEAM APPLICATIONS (IBAB.BR) Stock Price, Forecast & Analysis

IBAB.BR Latest News, Press Relases and Analysis